Ge, F., Xu, N., Bai, Y., Ba, Y., Zhang, Y., Li, F., . . . Xu, J. (2014). S-1 as Monotherapy or in Combination With Leucovorin as Second-Line Treatment in Gemcitabine-Refractory Advanced Pancreatic Cancer: A Randomized, Open-Label, Multicenter, Phase II Study. Oncologist.
Styl cytowania ChicagoGe, Feijiao, et al. "S-1 As Monotherapy or in Combination With Leucovorin As Second-Line Treatment in Gemcitabine-Refractory Advanced Pancreatic Cancer: A Randomized, Open-Label, Multicenter, Phase II Study." Oncologist 2014.
Styl cytowania MLAGe, Feijiao, et al. "S-1 As Monotherapy or in Combination With Leucovorin As Second-Line Treatment in Gemcitabine-Refractory Advanced Pancreatic Cancer: A Randomized, Open-Label, Multicenter, Phase II Study." Oncologist 2014.